Prognostic impact of initial maximum standardized uptake value of F-18-FDG PET/CT on treatment response in patients with metastatic lung adenocarcinoma treated with erlotinib
ONCOTARGETS AND THERAPY, cilt.8, ss.3749-3756, 2015 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 8
- Basım Tarihi: 2015
- Doi Numarası: 10.2147/ott.s94945
- Dergi Adı: ONCOTARGETS AND THERAPY
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.3749-3756
- Anahtar Kelimeler: lung adenocarcinoma, erlotinib, F-18-fluorodeoxyglucose positron emission tomography/computed tomography, maximum standardized uptake value, treatment response, prognosis, PLATINUM-BASED CHEMOTHERAPY, OPEN-LABEL, PHASE-III, 2ND-LINE TREATMENT, SMOKING HISTORY, SUPPORTIVE CARE, EGFR MUTATIONS, CANCER, GEFITINIB, MULTICENTER
- Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
- Akdeniz Üniversitesi Adresli: Evet
Özet
Purpose: To investigate whether the initial maximum standardized uptake value (SUVmax) on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18-FDG PET/CT) has a prognostic significance in metastatic lung adenocarcinoma.